KEY FEATURES
Full Name | Chromogranin A |
---|---|
Synonym | CHGA, CGA, chromogranin A |
Assay Type | Sandwich |
Reactivity | Human |
Range | 62.5-4000pg/mL |
Sensitivity | 37.5pg/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human CHGA in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CHGA. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CHGA and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CHGA, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CHGA. You can calculate the concentration of Human CHGA in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CHGA ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 203.03 | 633.03 | 1593 | 196.78 | 635.18 | 1681.5 |
Standard deviation | 10.19 | 29.82 | 79.01 | 13.26 | 36.21 | 67.26 |
CV(%) | 5.02 | 4.71 | 4.96 | 6.74 | 5.7 | 4 |
RECOVERY
The recovery of Human CHGA spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 88-101 | 93 |
EDTA plasma (n=8) | 93-105 | 98 |
Cell culture media (n=8) | 89-103 | 96 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CHGA in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CgA ELISA Kits
CHGB ELISA Kit | publications with CgA and CHGB |
STMN2 ELISA Kit | publications with CgA and STMN2 |
SCG2 ELISA Kit | publications with CgA and SCG2 |
GAST ELISA Kit | publications with CgA and GAST |
SCG3 ELISA Kit | publications with CgA and SCG3 |
Pathways associated with CgA ELISA Kit
Antimicrobial Peptides Pathway | Antimicrobial Peptides Pathway |
Immune System Pathway | Immune System Pathway |
Innate Immune System Pathway | Innate Immune System Pathway |
Diseases associated with CgA ELISA Kit
Hypertension | publications with CgA and Hypertension |
Pheochromocytoma | publications with CgA and Pheochromocytoma |
Cardiovascular Diseases | publications with CgA and Cardiovascular Diseases |
Prostatic Diseases | publications with CgA and Prostatic Diseases |
Nervous System Diseases | publications with CgA and Nervous System Diseases |
Lung Diseases | publications with CgA and Lung Diseases |
Hyperplasia | publications with CgA and Hyperplasia |
Kidney Diseases | publications with CgA and Kidney Diseases |
Carcinoma, Non-Small-Cell Lung | publications with CgA and Carcinoma, Non-Small-Cell Lung |
Liver Diseases | publications with CgA and Liver Diseases |
Organs/Tissues associated with CgA ELISA Kit
Nerve | publications with CgA and Nerve |
Adrenal Gland | publications with CgA and Adrenal Gland |
Prostate | publications with CgA and Prostate |
Lung | publications with CgA and Lung |
Stomach | publications with CgA and Stomach |
Brain | publications with CgA and Brain |
Thyroid | publications with CgA and Thyroid |
Pancreas | publications with CgA and Pancreas |
Parathyroid | publications with CgA and Parathyroid |
Kidney | publications with CgA and Kidney |